Filter by: Subject

Filter by: Subject

Results Per Page:

Neurology -- Research (1)
Neuromuscular disease (1)
Non-amyloid β-component (NAC) (1)
Nutraceuticals (1)
Obsessive-compulsive disorder (OCD) (1)
Oculopharyngeal muscular dystrophy (OPMD) (1)
Olfaction (1)
Olfactory bulb (1)
PABPN1 gene (1)
Parkinson's disease (1)
Parkinsonism (1)
Paroxysmal dyskinesia (1)
Paroxysmal nonkinesigenic dyskinesia (PNKD) (1)
Patient (1)
Patient mortality data (1)
Pedagogy (1)
Phakomatoses (1)
Phenotype (1)
Photobiomodulation (1)
Platelets (1)
Polyadenylate binding protein nuclear 1 (PABPN1) (1)
Porphyria (1)
Posterior reversible encephalopathy syndrome (PRES) (1)
PP2A Phosphatase Activator (PTPA) (1)
Pretoria, South Africa (1)
Prognostic indicators (1)
Progressive multifocal leucoencephalopathy (PML) (1)
Progressive multifocal leukoencephalopathy (PML) (1)
Protein phosphatase 2A complex (PP2A) (1)
Pseudo-tumors (1)
Psychosis (1)
Radiography (1)
Retina (1)
Scoliosis (1)
SDG-04: Quality education (1)
Self injurious behavior (1)
Severe neuropathy (1)
Social behaviour (1)
South Africa (1)
South African (1)
South African hospital (1)
South African neurology unit (1)
South African patients (1)
Spine -- Abnormalities (1)
STARD7 (1)
Sub-Saharan Africa (1)
Sub-Saharan Africa (SSA) (1)
Subcortical infarcts (1)
Suprasellar cyst (1)
Surgery (1)
Synucleinopathies (1)
Thrombo-embolic ischemic stroke (1)
Thromboelastography® (1)
Thymidine phosphorylase (TP) (1)
TOR1A mutations (1)
Tourette syndrome (TS) (1)
Transient ischemic attack (TIA) (1)
Treatment response (1)
Treatment-induced encephalopathy (1)
Trypanosoma brucei (1)
Turmeric (1)
Variegate porphyria (VP) (1)
Vasogenic oedema (1)
Vasopressin (1)
Viral disease (1)
Waterfall sign (1)
Western studies (1)